Bromide

Bromide

SCHEMBL8072708

Br.CC(C)(C#N)c1cc(Cn2cnc(N)n2)cc(C(C)(C)C#N)c1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 12/20 0.58
UGT1A4 P22310 1/20 0.58
PDE4D Q08499 1/20 0.58
ESR1 P03372 1/20 0.38
STS P08842 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13530998 0.83 CYP19A1 (0.60) CYP19A1UGT1A4PDE4DESR1STS
SCHEMBL13529281 0.81 CYP19A1 (0.54) CYP19A1UGT1A4PDE4DESR1STS
SCHEMBL13529283 0.79 CYP19A1 (0.55) CYP19A1UGT1A4PDE4DESR1STS
SCHEMBL13524699 0.79 CYP19A1 (0.55) CYP19A1UGT1A4PDE4DESR1STS
SCHEMBL13524701 0.78 CYP19A1 (0.54) CYP19A1UGT1A4PDE4DESR1STS
SCHEMBL13524702 0.77 CYP19A1 (0.53) CYP19A1UGT1A4PDE4DESR1STS
SCHEMBL13531036 0.75 CYP19A1 (0.51) CYP19A1UGT1A4PDE4DESR1STS
SCHEMBL13524698 0.75 CYP19A1 (0.51) CYP19A1UGT1A4PDE4DESR1STS
Anastrozole SCHEMBL5917785 0.75 CYP19A1 (0.97) CYP19A1UGT1A4PDE4DESR1STS
SCHEMBL13524700 0.74 CYP19A1 (0.50) CYP19A1UGT1A4PDE4DESR1STS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE36617-E Anastrozole and salts as anticancer agent ZENECA LIMITED (GB) 2000-03-14 US disclosed
US-4935437-A (Substituted aralkyl) heterocyclic compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-06-19 US disclosed